Definium Therapeutics, Inc. Payments for (Proceeds from) Other Investing Activities
Definium Therapeutics, Inc. (DFTX) reported Payments for (Proceeds from) Other Investing Activities of $113.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2022-11-10
- Definium Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2021-09-30 was $27.00K.
- Definium Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2021-06-30 was $67.00K.
- Definium Therapeutics, Inc. payments for (proceeds from) other investing activities for the quarter ending 2021-03-31 was $19.00K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month |
|---|---|---|---|
| 2021-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $94.00K derived: sum of 2 quarters · filed 2022-11-10 | $113.00K 10-Q · filed 2022-11-10 |
| 2021-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $86.00K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $19.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |